Matches in Wikidata for { <http://www.wikidata.org/entity/Q66061360> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66061360 description "clinical trial" @default.
- Q66061360 description "ensayu clínicu" @default.
- Q66061360 description "klinisch onderzoek" @default.
- Q66061360 description "клінічне випробування" @default.
- Q66061360 name "Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)" @default.
- Q66061360 name "Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers" @default.
- Q66061360 type Item @default.
- Q66061360 label "Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)" @default.
- Q66061360 label "Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers" @default.
- Q66061360 prefLabel "Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)" @default.
- Q66061360 prefLabel "Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers" @default.
- Q66061360 P1050 Q66061360-DE087323-EBB2-4C69-BF7C-2F72FE49080E @default.
- Q66061360 P1132 Q66061360-B7E25427-BA84-4C0E-B780-5573E737283A @default.
- Q66061360 P1476 Q66061360-526C58D6-F1F3-4894-80B4-C345226EA708 @default.
- Q66061360 P17 Q66061360-2F0C507E-4F98-4C9B-8FDB-C27A467DB17C @default.
- Q66061360 P2899 Q66061360-C8CC6D60-50A9-4756-B3E9-9F17104BA0BE @default.
- Q66061360 P3098 Q66061360-86C0D2B8-EFF0-4A0E-93DD-33827D1C7686 @default.
- Q66061360 P31 Q66061360-A8A591AC-8FB3-4E42-BBFD-1C350171F971 @default.
- Q66061360 P580 Q66061360-64A961C7-6C6F-418A-905D-52EBFE42EB6B @default.
- Q66061360 P582 Q66061360-C67B4637-8B63-4E10-87F5-E9C11E0D9DA4 @default.
- Q66061360 P6099 Q66061360-98816098-C635-410A-83DB-C180612CFBE8 @default.
- Q66061360 P6153 Q66061360-46AEE89F-496B-4418-AE12-5F21F67E11CB @default.
- Q66061360 P8363 Q66061360-256C4099-EE0C-4099-8E8F-6434DF6B918A @default.
- Q66061360 P1050 Q356033 @default.
- Q66061360 P1132 "+74" @default.
- Q66061360 P1476 "Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)" @default.
- Q66061360 P17 Q30 @default.
- Q66061360 P2899 "+18" @default.
- Q66061360 P3098 "NCT04021108" @default.
- Q66061360 P31 Q30612 @default.
- Q66061360 P580 "2019-07-22T00:00:00Z" @default.
- Q66061360 P582 "2022-01-08T00:00:00Z" @default.
- Q66061360 P6099 Q42824440 @default.
- Q66061360 P6153 Q49115 @default.
- Q66061360 P8363 Q78089383 @default.